Suggestions
Mary-Jane Elliott
Managing Partner at ICR Consilium
Mary-Jane Elliott is the Founder and Managing Partner of Consilium Strategic Communications, a leading healthcare communications firm.13 She co-founded Consilium in July 2013 after leading a management buy-out from M::no-wrap[Communications.6]
With over 20 years of experience in the healthcare industry, Mary-Jane is an expert in financial, corporate, and scientific communications as well as media management.45 Her expertise spans across pharmaceutical companies and leading communications agencies.5
Key points about Mary-Jane Elliott:
-
Leadership: She continues to lead Consilium from its headquarters in London.1
-
Acquisition: In 2023, Consilium was acquired by ICR, creating a global leader in healthcare communications and investor relations. Mary-Jane joined the ICR healthcare leadership team as part of this acquisition.12
-
Global impact: Under her leadership, Consilium has grown to become the market leader in healthcare strategic communications and investor relations in Europe.1
-
Client focus: Mary-Jane has advised on various high-profile friendly and hostile M&A transactions.4
-
Team building: She has built a team of over 45 PR and investor relations professionals at Consilium.2
-
Anniversary reflection: In July 2023, Mary-Jane reflected on Consilium's 10-year journey, emphasizing the importance of positive thinking in the company's success.7
Mary-Jane Elliott's leadership has been instrumental in establishing Consilium as a prominent player in the healthcare communications sector, culminating in its recent acquisition by ICR to form a global powerhouse in the field.
Highlights
ICR Consilium are hiring! We are recruiting an experienced bookkeeper to be a key support for the UK and US teams. If you or someone in your network would be interested, please apply following the link below.
#Hiring #Bookkeeper #JobOpportunity
Don't forget it's our IPO Bootcamp this morning. Together with Goodwin, we're hosting a free to attend event with talks from leaders at JPMorgan Chase & Co. and Nasdaq and a panel that I'll be chairing where we'll discuss how to pull off a successful IPO with several CEOs and CFOs who have already been through it! The panel discussion will cover timing, interacting with investors, assembling your team and optimising your Board, the selection of banks and how to be ready for post IPO life.
At ICR Consilium, we've successfully advised many companies including MoonLake Immunotherapeutics (NASDAQ: MLTX), Immunocore, Ablynx and Compass Pathways on their debuts to quoted company life.
Please come join us this morning from 9.30am -11.45am BST if you want to learn more about the IPO process or at our Annual Healthcare Conference which is finally here and starting today at 12pm! For last-minute registrations, please visit: https://lnkd.in/eeGeMqXV
Please get in touch with ICR Consilium if you’d like to attend our events: [email protected]
I look forward to seeing you all there for what is set to be a very busy and fun conference week ahead!
hashtag
#ICRConsiliumHC #HealthcareConference
